Unbalanced estrogen metabolism in ovarian cancer

No abstract is available for this paper.

• Publication year

  2014

• Venue

  International Journal of Cancer

• Publication date

  2014-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/ijc.28565PMID 24170413PMCID PMC3949171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unbalanced estrogen metabolism in thyroid cancer

  2013cited by this paper
• Ovarian cancer: etiology, risk factors, and epidemiology.

  2012cited by this paper
• Evaluation of serum estrogen-DNA adducts as potential biomarkers for breast cancer risk.

  2012cited by this paper
• Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer.

  2011cited by this paper
• Urine Biomarkers of Risk in the Molecular Etiology of Breast Cancer

  2009cited by this paper
• Urinary biomarkers suggest that estrogen-DNA adducts may play a role in the aetiology of non-Hodgkin lymphoma

  2009cited by this paper
• Novel biomarkers for risk of prostate cancer: Results from a case–control study

  2009cited by this paper
• CYP1B1 variants are associated with prostate cancer in non-Hispanic and Hispanic Caucasians

  2008cited by this paper
• Risk Factors for Ovarian Cancer: An Overview with Emphasis on Hormonal Factors

  2008cited by this paper
• Hormonal risk factors for ovarian cancer in premenopausal and postmenopausal women.

  2008cited by this paper
• Association between genetic polymorphisms and ovarian cancer risk.

  2008cited by this paper
• Combination of polymorphisms from genes related to estrogen metabolism and risk of prostate cancers: the hidden face of estrogens.

  2007cited by this paper
• The molecular etiology of breast cancer: Evidence from biomarkers of risk

  2007cited by this paper
• The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumor-initiating activity.

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003, National Cancer Institute. Bethesda, MD,

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003

  2006cited by this paper
• Ovarian Cancer Risk and Polymorphisms Involved in Estrogen Catabolism

  2006cited by this paper
• Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats.

  2006cited by this paper
• Quality and Quantity of Saliva DNA Obtained from the Self-administrated Oragene Method—A Pilot Study on the Cohort of Swedish Men

  2006cited by this paper
• Potential biomarker for early risk assessment of prostate cancer

  2006cited by this paper
• Synthesis of the catechols of natural and synthetic estrogens by using 2-iodoxybenzoic acid (IBX) as the oxidizing agent.

  2005cited by this paper
• Relative imbalances in the expression of estrogen-metabolizing enzymes in the breast tissue of women with breast carcinoma.

  2005cited by this paper
• Estrogen Bioactivation, Genetic Polymorphisms, and Ovarian Cancer

  2005cited by this paper
• A common CYP1B1 polymorphism is associated with 2-OHE1/16-OHE1 urinary estrone ratio

  2005cited by this paper
• Cigarette smoking and increased risk of mucinous epithelial ovarian cancer.

  2004cited by this paper
• Metabolism and DNA binding studies of 4-hydroxyestradiol and estradiol-3,4-quinone in vitro and in female ACI rat mammary gland in vivo.

  2003cited by this paper
• Evidence that a burst of DNA depurination in SENCAR mouse skin induces error-prone repair and forms mutations in the H-ras gene

  2001cited by this paper
• Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer

  2001cited by this paper
• Case-control study of ovarian cancer and polymorphisms in genes involved in catecholestrogen formation and metabolism.

  2001cited by this paper
• Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms.

  2001cited by this paper
• Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens.

  2000cited by this paper
• Cancer statistics, 2000

  2000cited by this paper
• Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: association of polymorphisms with functional differences in estrogen hydroxylation activity.

  2000cited by this paper
• Synthesis and structure elucidation of estrogen quinones conjugated with cysteine, N-acetylcysteine, and glutathione.

  1998cited by this paper
• Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides.

  1996cited by this paper
• Synthesis and characterization of estrogen 2,3- and 3,4-quinones. Comparison of DNA adducts formed by the quinones versus horseradish peroxidase-activated catechol estrogens.

  1992cited by this paper
• Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism.

  1987cited by this paper
• Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism.

  1987cited by this paper
• Carcinogenicity of catechol estrogens in Syrian hamsters.

  1986cited by this paper

• Impact of single nucleotide variants in estrogen genes on ovarian cancer risk: a systematic review and meta-analysis

  2025cites this paper
• Heme-thiolate monooxygenase cytochrome P450 1B1, an old dog with many new tricks.

  2025cites this paper
• Human Cytochrome P450 Cancer-Related Metabolic Activities and Gene Polymorphisms: A Review

  2024cites this paper
• Steroid sulfatase and sulfotransferases in the estrogen and androgen action of gynecological cancers: current status and perspectives

  2024cites this paper
• Estrogen regulates PDPK1 to promote cell proliferation in epithelial ovarian cancer

  2024cites this paper
• Cancer-associated adipocytes in the ovarian cancer microenvironment.

  2024cites this paper
• Calcium signals and potential therapy targets in ovarian cancer (Review)

  2023cites this paper
• Diabetes risk reduction diet and ovarian cancer risk: an Italian case-control study

  2023cites this paper
• Estrogen promotes Epithelial ovarian cancer cells proliferation via down-regulating expression and activating phosphorylation of PTEN.

  2023cites this paper
• Estrogen genotoxicity causes preferential development of Fuchs endothelial corneal dystrophy in females

  2023cites this paper
• Profiling the metabolome of uterine fluid for early detection of ovarian cancer

  2023cites this paper
• Gut Microbes in Gynecologic Cancers: Causes or Biomarkers and Therapeutic Potential

  2022cites this paper
• The Influence of Interaction between Cadmium with 17β-Estradiol, 2-Methoxyestradiol and 16α-Hydroxyestrone on Viability and p-Glycoprotein in Ovarian Cancer Cell Line

  2022cites this paper
• Model Cell Lines and Tissues of Different HGSOC Subtypes Differ in Local Estrogen Biosynthesis

  2022cites this paper
• Correlations between salivary- and blood-derived gonadal hormone assessments and implications for inclusion of female participants in research studies.

  2022cites this paper
• The 3,4-Quinones of Estrone and Estradiol Are the Initiators of Cancer whereas Resveratrol and N-acetylcysteine Are the Preventers

  2021cites this paper
• Relationship between 17𝜷 estradiol (17𝜷E) levels and Catechol -O- methyltransferase (COMT) levels in ovarian cancers

  2021influential citation
• The ovarian carcinoma risk with the polymorphisms of CYP1B1 come from the positive selection.

  2021cites this paper
• Targeting Adipokines in Obesity-Related Tumors

  2021cites this paper
• 17β‐Estradiol via Orai1 activates calcium mobilization to induce cell proliferation in epithelial ovarian cancer

  2020cites this paper
• Adenomyosis: genetics of estrogen metabolism

  2019cites this paper
• Current strategies for quantification of estrogens in clinical research

  2019cites this paper
• Modulation of Estrogen Metabolism and Prevention of Pathologies

  2019cites this paper
• Title Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer : the B ∼ FIT Cohort . Permalink

  2019cites this paper
• The Mercapturomic Profile of Health and Non-Communicable Diseases

  2019cites this paper
• Ultraviolet A light induces DNA damage and estrogen-DNA adducts in Fuchs endothelial corneal dystrophy causing females to be more affected

  2019cites this paper
• Loss of NQO1 generates genotoxic estrogen-DNA adducts in Fuchs Endothelial Corneal Dystrophy.

  2019cites this paper
• Key regulator of cellular metabolism, estrogen-related receptor α, a new therapeutic target in endocrine-related gynecological tumor

  2018cites this paper
• A role for G-protein coupled estrogen receptor (GPER) in estrogen-induced carcinogenesis: Dysregulated glandular homeostasis, survival and metastasis.

  2018cites this paper
• Estrogen Metabolism in African-American Women with and without Breast Cancer: A Pilot Study.

  2018cites this paper
• Ovarian Cancer in Sudan

  2017cites this paper
• Estrogen Metabolites in the Etiology of Hormone Related Cancers: Possible Role of Anti-Oxidants in Prevention

  2017cites this paper
• Etiology and prevention of prevalent types of cancer

  2017cites this paper
• Critical depurinating DNA adducts: Estrogen adducts in the etiology and prevention of cancer and dopamine adducts in the etiology and prevention of Parkinson's disease

  2017influential citation
• Estrogen Metabolism and Risk of Postmenopausal Endometrial and Ovarian Cancer: the B∼FIT Cohort

  2016cites this paper
• Inhibition of Depurinating Estrogen-DNA Adduct Formation in the Prevention of Breast and Other Cancers

  2016cites this paper
• Depurinating estrogen-DNA adducts, generators of cancer initiation: their minimization leads to cancer prevention

  2016cites this paper
• Human Biomonitoring of DNA Adducts by Ion Trap Multistage Mass Spectrometry

  2016cites this paper
• The Role of Steroid Hormones, GREB1, and Reproductive Status in Ovarian Cancer Progression

  2016influential citation
• Dietary fat intake and ovarian cancer risk: a meta-analysis of epidemiological studies

  2016cites this paper
• Impact of estrogen and progesterone receptor expression on the clinical and molecular features of papillary thyroid cancer.

  2015cites this paper
• Oxidative metabolism of estrogens in cancer initiation and prevention

  2015cites this paper
• Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently

  2015cites this paper
• A chromatography/tandem mass spectrometry method for the simultaneous profiling of ten endogenous steroids, including progesterone, adrenal precursors, androgens and estrogens, using low serum volume.

  2015cites this paper
• Breast Health and Reducing Breast Cancer Risk: A Functional Medicine Approach

  2015cites this paper
• The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity.

  2014cites this paper
• CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro

  2014cites this paper
• cyclo-CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro

  year unknowncites this paper